| Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation PJ Campbell, EJ Baxter, PA Beer, LM Scott, AJ Bench, BJP Huntly, ... Blood 108 (10), 3548-3555, 2006 | 377 | 2006 |
| V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosis PJ Campbell, M Griesshammer, K Döhner, H Döhner, R Kusec, ... Blood 107 (5), 2098-2100, 2006 | 331 | 2006 |
| Two routes to leukemic transformation after a JAK2 mutation–positive myeloproliferative neoplasm PA Beer, F Delhommeau, JP LeCouédic, MA Dawson, E Chen, ... Blood, The Journal of the American Society of Hematology 115 (14), 2891-2900, 2010 | 328 | 2010 |
| AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t (8; 21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation. R Kusec, K Laczika, P Knöbl, J Friedl, H Greinix, P Kahls, W Linkesch, ... Leukemia 8 (5), 735-739, 1994 | 200 | 1994 |
| Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia D Schmid, G Heinze, B Linnerth, K Tisljar, R Kusec, K Geissler, C Sillaber, ... Leukemia 11 (5), 639-643, 1997 | 156 | 1997 |
| Templated nucleotide addition and immunoglobulin JH-gene utilization in t (11; 14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma N Welzel, T Le, R Marculescu, G Mitterbauer, A Chott, C Pott, M Kneba, ... Cancer research 61 (4), 1629-1636, 2001 | 151 | 2001 |
| Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes H Dolatshad, A Pellagatti, FG Liberante, M Llorian, E Repapi, V Steeples, ... Leukemia 30 (12), 2322-2331, 2016 | 136 | 2016 |
| High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B‐cell chronic … B Jaksic, M Brugiatelli, I Krc, H Losonczi, J Holowiecki, A Planinc‐Peraica, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 1997 | 120 | 1997 |
| MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival J Chi, E Ballabio, XH Chen, R Kušec, S Taylor, D Hay, D Tramonti, ... Biology direct 6, 1-17, 2011 | 118 | 2011 |
| Telomere length in myelodysplastic syndromes J Boultwood, C Fidler, R Kusec, K Rack, PJW Elliott, O Atoyebi, ... American journal of hematology 56 (4), 266-271, 1997 | 103 | 1997 |
| High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression J Boultwood, J Perry, R Zaman, C Fernandez-Santamaria, T Littlewood, ... Leukemia 24 (6), 1139-1145, 2010 | 95 | 2010 |
| Amplification of mitochondrial DNA in acute myeloid leukaemia J Boultwood, C Fidler, KI Mills, PM Frodsham, R Kusec, A Gaiger, ... British journal of haematology 95 (2), 426-431, 1996 | 95 | 1996 |
| Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET) G Barosi, D Bordessoule, J Briere, F Cervantes, JL Demory, B Dupriez, ... Blood 106 (8), 2849-2853, 2005 | 86 | 2005 |
| B and CTL responses to the ALK protein in patients with ALK‐positive ALCL K Ait‐Tahar, V Cerundolo, AH Banham, C Hatton, T Blanchard, R Kusec, ... International journal of cancer 118 (3), 688-695, 2006 | 82 | 2006 |
| hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia LJ Campbell, C Fidler, H Eagleton, A Peniket, R Kusec, S Gal, ... Leukemia 20 (4), 671-679, 2006 | 77 | 2006 |
| Clinical applications of PCR YMD Lo Springer Science & Business Media, 2008 | 74 | 2008 |
| More on prognostic significance of FLT3/ITD size in acute myeloid leukemia (AML) R Kusec, O Jaksic, S Ostojic, I Kardum-Skelin, R Vrhovac, B Jaksic Blood 108 (1), 405-406, 2006 | 74 | 2006 |
| More on prognostic significance of FLT3/ITD size in acute myeloid leukemia (AML) R Kusec, O Jaksic, S Ostojic, I Kardum-Skelin, R Vrhovac, B Jaksic Blood 108 (1), 405-406, 2006 | 74 | 2006 |
| CD38 on B-cell chronic lymphocytic leukemia cells has higher expression in lymph nodes than in peripheral blood or bone marrow O Jaksic, MM Kardum Paro, I Kardum Skelin, R Kusec, V Pejsa, B Jaksic Blood 103 (5), 1968-1969, 2004 | 69 | 2004 |
| Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia J Boultwood, C Fidler, P Shepherd, F Watkins, J Snowball, S Haynes, ... American journal of hematology 61 (1), 5-9, 1999 | 68 | 1999 |
